{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:20:13Z","timestamp":1781554813737,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clindermatol.2020.06.013","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:55:07Z","timestamp":1593528907000},"page":"641-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus"],"prefix":"10.1016","volume":"38","author":[{"given":"Kyle","family":"McNamara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia Bosshardt","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Chaney","family":"Strowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.06.013_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1081-1206(10)61804-2","article-title":"Drug allergy in a general hospital: results of a novel prospective inpatient reporting system","volume":"90","author":"Thong","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0010","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10067-017-3777-4","article-title":"Demographic and clinical characteristics of patients with serum sickness-like reaction","volume":"37","author":"Yorulmaz","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJM198411293112204","article-title":"A prospective clinical and immunologic analysis of patients with serum sickness","volume":"311","author":"Lawley","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40272-013-0039-z","article-title":"Cutaneous drug reactions in children: an update","volume":"15","author":"Heelan","year":"2013","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0035","first-page":"403","article-title":"Cutaneous drug reactions in the pediatric population","volume":"61","author":"Noguera-Morel","year":"2014","journal-title":"Pediatr Clin"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9343(96)00405-6","article-title":"Clinical features and outcome of 95 patients with hypersensitivity vasculitis","volume":"102","author":"Martinez-Taboada","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cup.12863","article-title":"Serum sickness-like drug reaction: two cases with a neutrophilic urticarial pattern","volume":"44","author":"Nguyen","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.134.3.7","article-title":"Quantitation of acute and chronic serum sickness in the rabbit","volume":"134","author":"Wilson","year":"1971","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/ACI.0b013e3283489d5f","article-title":"Symmetrical drug-related intertriginous and flexural exanthema","volume":"11","author":"Tan","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.0105-1873.2004.00445.x","article-title":"Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?","volume":"51","author":"H\u00e4usermann","year":"2004","journal-title":"Contact Derm"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0075","doi-asserted-by":"crossref","DOI":"10.5070\/D32WS5H2S0","article-title":"Systemic drug-related intertriginous and flexural exanthema (SDRIFE)","volume":"15","author":"Elmariah","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000018047","article-title":"Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome)","volume":"197","author":"Helmbold","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0085","series-title":"Dermatology","author":"Bolognia","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000018259","article-title":"A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis","volume":"199","author":"Barbaud","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2015.03.015","article-title":"Granulomatous drug eruptions","volume":"33","author":"Dodiuk-Gad","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0100","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jaad.2007.11.004","article-title":"Interstitial granulomatous drug reaction to anakinra","volume":"59","author":"Regula","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaad.2004.11.028","article-title":"Interstitial granulomatous drug reaction caused by Chinese herbal medication","volume":"52","author":"Lee","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2015.03.005","article-title":"Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification","volume":"33","author":"Rosenbach","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0115","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1365-2133.2008.08560.x","article-title":"Interstitial granulomatous drug reaction following intravenous ganciclovir","volume":"158","author":"Pini","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0560.1998.tb01693.x","article-title":"The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity","volume":"25","author":"Magro","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.semdp.2017.11.003","article-title":"Drug induced pseudolymphoma","volume":"35","author":"Magro","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0130","doi-asserted-by":"crossref","unstructured":"Tian Z, Shiyu Z, Tao W, et al. Lymphoma or pseudolymphoma: A report of six cases and review of the literature. Dermatol Ther. 2018:e12807.","DOI":"10.1111\/dth.12807"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002281-199909000-00006","article-title":"Etiology and mechanisms of drug-induced lupus","volume":"11","author":"Rubin","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14740338.2015.995089","article-title":"Drug-induced lupus","volume":"14","author":"Rubin","year":"2015","journal-title":"Exp Opin Drug Saf"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/tx980001t","article-title":"Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages","volume":"12","author":"Goebel","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0150","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0022-3565(25)39181-0","article-title":"Cytotoxicity of oxidative metabolites of procainamide","volume":"242","author":"Rubin","year":"1987","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0155","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.154.6.3025","article-title":"Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo","volume":"154","author":"Yung","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0160","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI119356","article-title":"Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus","volume":"99","author":"Kretz-Rommel","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/pgmj.46.542.729","article-title":"Quinidine-induced systemic lupus erythematosus","volume":"46","author":"Kendall","year":"1970","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Dalle Vedove","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart","volume":"165","author":"Marzano","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.013_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2019.02.009","article-title":"Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study","volume":"81","author":"Guicciardi","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:10Z","timestamp":1760033770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0738081X20301462"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}